NIH Funds USF, Aetna to Study BRCA Testing | GenomeWeb

NEW YORK (GenomeWeb News) – The University of South Florida will use a $2.8 million grant from the National Institutes of Health to partner with Aetna and patient advocates to study how genetic testing for breast cancer risk can impact clinical decisions made by patients and doctors.

USF said today that the five-year American BRCA Outcomes Among Recently Diagnosed (ABOARD) study could fill a gap in knowledge about how breast cancer risk tests are being used and could guide policies and services to help patients and doctors make better health decisions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.